VanEck Pharmaceutical ETF (PPH) — ETF Analysis on Winston

Key Facts

• Issuer: VanEck
• Asset Class: Stock
• Price: $116.63
• Expense Ratio: 36.00%
• Assets Under Management: $966M
• Number of Holdings: 26
• Inception Date: 2011-12-20
• Currency: USD

Winston Score

VanEck Pharmaceutical ETF has a Winston Score of 65 out of 100.

Performance

• 1-Year Return: 32.68%
• 3-Year Return: 43.05%
• 5-Year Return: 52.68%

Top Holdings

Eli Lilly & Co (N/A%), Novartis Ag (N/A%), Merck & Co Inc (N/A%), Novo Nordisk A/S (N/A%), Bristol-Myers Squibb Co (N/A%)

Sector Breakdown

Healthcare (N/A%)